| |
|
June 4, 2012
Formula Pharmaceuticals Appoints Morton Collins to Board of Directors
January 24, 2012
Formula Pharmaceuticals Appoints Martyn Greenacre to Board of Directors
 December
8, 2011
Formula Pharmaceuticals featured in BioWorld Today "Looking
for Magic ‘Formula’ in Cancer Maintenance Therapy"
DOWNLOAD PDF
|
|
Formula Pharmaceuticals, Inc. is a privately-held, oncology drug development company advancing novel medicines to address areas of unmet therapeutic need in cancer. Formula’s lead product candidate, FPI-01, is a first-in-class immunotherapeutic in clinical development for the maintenance of first-remission in acute myeloid leukemia (AML) and other cancers. Building upon deep industry expertise in identifying, licensing and developing novel medical approaches, Formula's
focus is on accelerating future life-saving cancer therapies.
Learn
more >
|
|
|
